0 Commentaires
0 Parts
522 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Marketplace
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
In Vivo CRO Market to Reach USD 10.07 Billion by 2033, Driven by Growing Global Research StandardsThe global in vivo CRO market size was valued at USD 4.95 billion in 2024, and it is projected to reach USD 5.36 billion in 2025 to USD 10.07 billion by 2033, growing at a CAGR of 8.2% during the forecast period (2025–2033). The rising international standards adoption by contract researchers in emerging nations is projected to improve demand for...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Clinical Trials SMO Market to Reach USD 3.2 Billion by 2034 | CAGR 6.3%According to a newly published market research report by 24LifeSciences, global Clinical Trials Site Management Organizations (SMO) market was valued at USD 1.84 billion in 2025 and is projected to reach USD 3.2 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period 2026–2034. Clinical Trials Site Management Organizations are specialized...0 Commentaires 0 Parts 558 Vue 0 Aperçu
-
In Vivo Toxicology Market to Reach USD 6.37 Billion by 2031 | CAGR 6.1%According to a newly published market research report by 24LifeSciences, the global In Vivo Toxicology market was valued at USD 4.27 billion in 2024 and is projected to reach USD 6.37 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 20252031. In Vivo Toxicology represents an essential component of preclinical drug development, employing whole...0 Commentaires 0 Parts 83 Vue 0 Aperçu
-
In Vivo Toxicology Market to Reach USD 6.37 Billion by 2031 | CAGR 6.1%According to a newly published market research report by 24LifeSciences, the global In Vivo Toxicology market was valued at USD 4.27 billion in 2024 and is projected to reach USD 6.37 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 20252031. In Vivo Toxicology represents an essential component of preclinical drug development, employing whole...0 Commentaires 0 Parts 77 Vue 0 Aperçu
Commandité
Commandité